{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:04:47Z","timestamp":1778537087486,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jdiacomp.2018.06.006","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T07:44:00Z","timestamp":1528875840000},"page":"870-875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Diabetes management before, during, and after bariatric and metabolic surgery"],"prefix":"10.1016","volume":"32","author":[{"given":"Karim G.","family":"Kheniser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta R.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0005","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/dc08-2127","article-title":"Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward","volume":"32","author":"Turchin","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/eje.1.02321","article-title":"Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery","volume":"156","author":"Noordzij","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11695-010-0337-2","article-title":"Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese","volume":"21","author":"Edholm","year":"2011","journal-title":"Obes Surg"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0020","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/archsurg.2011.273","article-title":"Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study","volume":"146","author":"van Nieuwenhove","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0025","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.soard.2014.07.018","article-title":"Changes in liver volume and body composition during 4\u202fweeks of low calorie diet before laparoscopic gastric bypass","volume":"11","author":"Edholm","year":"2015","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0030","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1210\/jc.2011-3178","article-title":"Effects of adding exercise to a 16-week very low-calorie diet in obese, insulin-dependent type 2 diabetes mellitus patients","volume":"97","author":"Snel","year":"2012","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0035","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1177\/193229681200600528","article-title":"Treatment of diabetes prior to and after bariatric surgery","volume":"6","author":"Thorell","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0040","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2146\/ajhp120607","article-title":"Hypertension and diabetes mellitus medication management in sleeve gastrectomy patients","volume":"70","author":"Bland","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0045","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.2337\/dc17-0595","article-title":"Pharmacologic differences of sulfonylureas and the risk of adverse cardiovascular and hypoglycemic events","volume":"40","author":"Douros","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2337\/dc06-1679","article-title":"Glucose measurement: confounding issues in setting targets for inpatient management","volume":"30","author":"Dungan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00592-015-0745-9","article-title":"Frequency of self-monitoring blood glucose and attainment of HbA1c target values","volume":"53","author":"Elgart","year":"2016","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0060","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/dc12-1988","article-title":"Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0065","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/jc.2013-2538","article-title":"Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones","volume":"98","author":"Nannipieri","year":"2013","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0070","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.soard.2011.08.002","article-title":"Preoperative hemoglobin A1c and postoperative glucose control in outcomes after gastric bypass for obesity","volume":"8","author":"Perna","year":"2012","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4158\/EP12437.GL","volume":"19","author":"Mechanick","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0080","first-page":"353","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"15","author":"Moghissi","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0085","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.2337\/dc17-S017","article-title":"Diabetes care in the hospital","volume":"40","author":"Association AD","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0090","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.smj.0000209366.91803.99","article-title":"Perioperative glucose control in the diabetic or nondiabetic patient","volume":"99","author":"Smiley","year":"2006","journal-title":"South Med J"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0095","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.2174\/138161212803832236","article-title":"Hyperglycemia and perioperative glucose management","volume":"18","author":"Duncan","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0100","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2337\/dc15-0160","article-title":"Comparison of basal-bolus and premixed insulin regimens in hospitalized patients with type 2 diabetes","volume":"38","author":"Bellido","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0105","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejim.2004.10.001","article-title":"Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes","volume":"15","author":"Boehm","year":"2004","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0110","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2337\/dc10-2434","article-title":"Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes","volume":"34","author":"Rubin","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0115","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/dc07-0295","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial)","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Daibetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/dc10-1407","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery)","volume":"34","author":"Umpierrez","year":"2011","journal-title":"Daibetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0125","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1210\/jc.2008-1441","article-title":"Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes","volume":"94","author":"Umpierrez","year":"2009","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0130","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4158\/EP15675.OR","article-title":"Basal-bolus regimen with insulin analogues versus human insulin in medical patients with type 2 diabetes: a randomized controlled trial in Latin America","volume":"21","author":"Bueno","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0135","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ijo.2009.254","article-title":"Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes","volume":"34","author":"Kashyap","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijsu.2013.02.007","article-title":"Sleeve gastrectomy and Roux-en-Y gastric bypass are equally effective in correcting insulin resistance","volume":"11","author":"Benaiges","year":"2013","journal-title":"Int J Surg"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0145","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0150","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes","volume":"366","author":"Schauer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11695-012-0754-5","article-title":"Roux-en Y gastric bypass surgery reduces hedonic hunger and improves dietary habits in severely obese subjects","volume":"23","author":"Ullrich","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3945\/ajcn.115.111732","article-title":"Energy and macronutrient intake after gastric bypass for morbid obesity: a 3-y observational study focused on protein consumption","volume":"103","author":"Giusti","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0165","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s11695-015-2043-6","article-title":"Food intake and changes in eating behavior after laparoscopic sleeve gastrectomy","volume":"26","author":"Coluzzi","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0170","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/SLA.0000000000001915","article-title":"Incidence and predictive factors of postprandial hyperinsulinemic hypoglycemia after roux-en-y gastric bypass: a five year longitudinal study","volume":"264","author":"Raverdy","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0175","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.2337\/dc18-S006","article-title":"6. Glycemic targets: Standards of medical care in diabetes-2018","volume":"41","author":"Association AD","year":"2018","journal-title":"Daibetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0180","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00464-016-5129-x","article-title":"The effects of optimal perioperative glucose control on morbidly obese patients undergoing bariatric surgery","volume":"31","author":"Zaman","year":"2017","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0185","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.2337\/dc15-2647","article-title":"Incidence and clinical reatures of diabetic ketoacidosis after bariatric and metabolic surgery","volume":"39","author":"Aminian","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0190","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2337\/dc15-2732","article-title":"Bariatric surgery in obese patients with type 1 diabetes","volume":"39","author":"Kirwan","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0195","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1007\/s11695-016-2106-3","article-title":"Bariatric surgery in obese patients with type 1 diabetes: effects on weight loss and metabolic control","volume":"26","author":"Faucher","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0200","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa1401329","article-title":"Bariatric surgery versus intensive medical therapy for diabetes\u20143-year outcomes","volume":"370","author":"Schauer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0205","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s11695-014-1375-y","article-title":"A retrospective review of the medical management of hypertension and diabetes mellitus following sleeve gastrectomy","volume":"25","author":"Tritsch","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0210","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jbmr.3002","article-title":"Type 2 diabetes and risk of hip fractures and non-skeletal fall injuries in the elderly: a study rrom the rractures and fall injuries in the elderly cohort (FRAILCO)","volume":"32","author":"Wallander","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0215","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/diacare.25.10.1749","article-title":"Older women with diabetes have a higher risk of falls: a prospective study","volume":"25","author":"Schwartz","year":"2002","journal-title":"Daibetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0220","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1210\/jc.2014-4341","article-title":"Two-year changes in bone density after Roux-en-Y gastric bypass surgery","volume":"100","author":"Yu","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0225","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/EJE-17-0014","article-title":"Bone structural changes after gastric bypass surgery evaluated by HR-pQCT: a two-year longitudinal study","volume":"176","author":"Shanbhogue","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0230","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/jbmr.3101","article-title":"Fracture risk after bariatric surgery: Roux-en-Y gastric bypass versus adjustable gastric banding","volume":"32","author":"Yu","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0235","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/en.2004-0735","article-title":"Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation","volume":"146","author":"Ali","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0240","first-page":"903","article-title":"Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo","volume":"148","author":"Lecka-Czernik","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0245","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/jc.2009-0572","article-title":"Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes","volume":"95","author":"Zinman","year":"2010","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0250","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-017-0232-2","article-title":"Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial","volume":"9","author":"Vianna","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9785890","article-title":"Metformin decreases reactive oxygen species, enhances osteogenic properties of adipose-derived multipotent mesenchymal stem cells in vitro, and increases bone density in vivo","volume":"2016","author":"Marycz","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2015-3167","article-title":"Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus","volume":"101","author":"Watts","year":"2016","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0265","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bone.2009.07.008","article-title":"Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD","volume":"45","author":"Henriksen","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0270","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/jc.2015-1176","article-title":"GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women","volume":"100","author":"Iepsen","year":"2015","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0275","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0280","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0285","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0290","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0295","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00125-014-3196-x","article-title":"Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes","volume":"57","author":"Polidori","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0300","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrendo.2012.140","article-title":"GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus","volume":"8","author":"Meier","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0305","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.2337\/dc14-0893","article-title":"Liraglutide and the preservation of pancreatic \u03b2-cell function in early type 2 diabetes: the LIBRA trial","volume":"37","author":"Retnakaran","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0310","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(09)60659-0","article-title":"Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)","volume":"374","author":"Buse","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0315","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2147\/DMSO.S90662","article-title":"SGLT2 inhibitors - an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin","volume":"8","author":"Seufert","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0320","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2337\/dc13-3007","article-title":"Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial","volume":"37","author":"\u00d8stoft","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.soard.2016.08.281","article-title":"Use of liraglutide for weight loss in patients with prior bariatric surgery","volume":"12","author":"Creange","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0330","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.soard.2016.02.013","article-title":"Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery","volume":"12","author":"Gorgojo-Mart\u00ednez","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0335","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2337\/dc10-2140","article-title":"Effect of gastric bypass surgery on the absorption and bioavailability of metformin","volume":"34","author":"Padwal","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0340","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/SLA.0b013e31827a0e82","article-title":"Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients","volume":"258","author":"Tandra","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0345","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrgastro.2013.119","article-title":"Mechanisms underlying weight loss after bariatric surgery","volume":"10","author":"Miras","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2018.06.006_bb0350","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/IJGM.S55332","article-title":"The use of drugs in patients who have undergone bariatric surgery","volume":"7","author":"Geraldo","year":"2014","journal-title":"Int J Gen Med"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687271830552X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687271830552X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T03:10:21Z","timestamp":1751685021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105687271830552X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S105687271830552X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.06.006","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes management before, during, and after bariatric and metabolic surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018","name":"copyright","label":"Copyright"}]}}